Aberrant CD200/CD200R1 expression and its potential role in Th17 cell differentiation, chemotaxis and osteoclastogenesis in rheumatoid arthritis

Rheumatology (United Kingdom)

Volumn 54, Issue 4, 2014, Pages 712-721

  Ren, Yan ^a,b   Yang, Bo ^a   Yin, Yufeng ^a   Leng, Xiaomei ^a   Jiang, Ying ^a   Zhang, Lei ^a   Li, Yongzhe ^a   Li, Xin ^a   Zhang, Fengchun ^a   He, Wei ^c   Zhang, Xuan ^a   Cao, Xuetao ^c  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

CD200 CD200R1; Osteoclastogenesis; Rheumatoid arthritis; Th17 cells

Indexed keywords

B7 ANTIGEN; CARBOXYFLUORESCEIN; CD200 ANTIGEN; CD200 RECEPTOR; CD200 RECEPTOR 1; CD86 ANTIGEN; COLONY STIMULATING FACTOR 1; INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LIPOCORTIN 5; METHOTREXATE; OSTEOCLAST DIFFERENTIATION FACTOR; PROPIDIUM IODIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW EDEMA; CD4+ T LYMPHOCYTE; CELL SEPARATION; CELL STIMULATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MALE; OSTEOCLASTOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; RHEUMATOID ARTHRITIS; SYNOVIUM; TH17 CELL; UPREGULATION; WESTERN BLOTTING;

EID: 84926482828     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu362     Document Type: Article

References (30)

1. Wright GJ, Cherwinski H, Foster-Cuevas M et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol 2003;171:3034-46.
2. Barclay AN, Wright GJ, Brooke G, Brown MH. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 2002;23:285-90.
3. Hatherley D, Barclay AN. The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur J Immunol 2004;34: 1688-94.
4. Gorczynski R, Chen Z, Kai Y et al. CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. J Immunol 2004;172:7744-9.
5. Gorczynski RM. CD200 and its receptors as targets for immunoregulation. Curr Opin Investig Drugs 2005;6: 483-8.
6. Akkaya M, Barclay AN. Heterogeneity in the CD200R paired receptor family. Immunogenetics 2010;62:15-22.
7. Rijkers ES, de Ruiter T, Baridi A et al. The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes. Mol Immunol 2008;45:1126-35.
8. Voehringer D, Rosen DB, Lanier LL, Locksley RM. CD200 receptor family members represent novel DAP12-associated activating receptors on basophils and mast cells. J Biol Chem 2004;279:54117-23.
9. Torrero MN, Larson D, Hubner MP, Mitre E. CD200R surface expression as a marker of murine basophil activation. Clin Exp Allergy 2009;39:361-9.
10. Talebian F, Liu JQ, Liu Z et al. Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions. PLoS One 2012;7: e31442.
11. Cherwinski HM, Murphy CA, Joyce BL et al. The CD200 receptor is a novel and potent regulator of murine and human mast cell function. J Immunol 2005;174:1348-56.
12. Gorczynski RM, Chen Z, Yu K, Hu J. CD200 immunoadhesin suppresses collagen-induced arthritis in mice. Clin Immunol 2001;101:328-34.
13. Gorczynski RM, Chen Z, Lee L, Yu K, Hu J. Anti-CD200R ameliorates collagen-induced arthritis in mice. Clin Immunol 2002;104:256-64.
14. Simelyte E, Criado G, Essex D et al. CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collageninduced arthritis. Arthritis Rheum 2008;58:1038-43.
15. Simelyte E, Alzabin S, Boudakov I, Williams R. CD200R1 regulates the severity of arthritis but has minimal impact on the adaptive immune response. Clin Exp Immunol 2010;162:163-8.
16. Li Y, Zhao LD, Tong LS et al. Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity. Arthritis Res Ther 2012;14:R123.
17. Hodgson RJ, O'Connor P, Moots R. MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy. Rheumatology 2008;47:13-21.
18. Baeten D, Demetter P, Cuvelier C et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis 2000;59:945-53.
19. Griffiths MR, Neal JW, Fontaine M, Das T, Gasque P. Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. J Immunol 2009;182:4368-77.
20. Broderick C, Hoek RM, Forrester JV et al. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol 2002;161:1669-77.
21. Li Y, Jiang L, Zhang S et al. Methotrexate attenuates the Th17/IL-17 levels in peripheral blood mononuclear cells from healthy individuals and RA patients. Rheumatol Int 2012;32:2415-22.
22. Pernis AB. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med 2009;265:644-52.
23. Lubberts E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine 2008;41: 84-91.
24. Palumbo GA, Parrinello N, Fargione G et al. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res 2009;33:1212-6.
25. Mihrshahi R, Barclay AN, Brown MH. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J Immunol 2009;183:4879-86.
26. Petersen J, Halkjaer-Kristensen J, Ingemann-Hansen T. Synovial fluid and blood monocytes/macrophages in rheumatoid arthritis. Influence on polyclonal activation of autologous B lymphocytes. Scand. J Rheumatol 1984;13: 265-72.
27. Highton J, Carlisle B, Palmer DG. Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 1995; 102:541-6.
28. Katschke KJ Jr, Rottman JB, Ruth JH et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001;44: 1022-32.
29. Yang Y, Lu N, Zhou J, Chen ZN, Zhu P. Cyclophilin A upregulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology 2008;47:1299-310.
30. Zhu P, Ding J, Zhou J et al. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production. Arthritis Res Ther 2005;7: R1023-R1033.